Product Information
CALCIUM ACETATE 667 MG CAPSULE is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1733 per EA under NDC 75834032302. Its NADAC has been published 98 times since Aug 14, 2024.
Strength
667 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834032302
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CALCIUM ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA217205On Market Since
12/7/2023
Pharmacological Classes
Price Statistics
The NADAC for CALCIUM ACETATE 667 MG CAPSULE has been published 98 times since Aug 14, 2024, and over the history we have for it it has risen 3.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1733 per EA |
|---|---|
| All-time high | $0.2245 (Sep 10, 2025) |
| All-time low | $0.1369 (Nov 20, 2024) |
| 52-week high | $0.2245 |
| 52-week low | $0.1722 |
| Median price | $0.1824 |
| Average price | $0.1876 |
| Largest weekly change | -27.2% (Nov 20, 2024) |
| Weeks tracked | 98 |
| Tracking since | Aug 14, 2024 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CALCIUM ACETATE 667 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CALCIUM ACETATE 667 MG CAPSULE, manufactured by Nivagen Pharmaceuticals Inc., is $0.1733 per EA (NDC 75834032302), effective Jun 24, 2026.
How has the price of CALCIUM ACETATE 667 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CALCIUM ACETATE 667 MG CAPSULE has risen 3.5%. It has been tracked across 98 weekly CMS publications since Aug 14, 2024.
What are the highest and lowest recorded NADAC prices for CALCIUM ACETATE 667 MG CAPSULE?
Since Aug 14, 2024, the NADAC for CALCIUM ACETATE 667 MG CAPSULE has ranged from a low of $0.1369 (Nov 20, 2024) to a high of $0.2245 (Sep 10, 2025), with a median of $0.1824 per EA.
Are there cheaper alternatives to CALCIUM ACETATE 667 MG CAPSULE?
8 NADAC-published products share the same active ingredient, strength, and dosage form as CALCIUM ACETATE 667 MG CAPSULE, but none are currently priced below it.
Who manufactures CALCIUM ACETATE 667 MG CAPSULE?
CALCIUM ACETATE 667 MG CAPSULE (NDC 75834032302) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification